ω-3 fatty acid treatment in cardiac syndrome X: a double-blind, randomized, placebo-controlled clinical study.

Bozcali E., Babalik E., Himmetoglu S., Mihmanli I., TOPRAK S.

Coronary artery disease, cilt.24, sa.4, ss.328-33, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 24 Sayı: 4
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1097/mca.0b013e32835f3005
  • Dergi Adı: Coronary artery disease
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.328-33
  • İstanbul Üniversitesi Adresli: Evet

Özet

Objective We conducted a clinical trial to examine the effect of omega-3 fatty acids in patients with cardiac syndrome X (CSX). We aimed to evaluate the potential impact of omega-3 fatty acids on endothelial function, oxidative stress, and symptom relief in the CSX.